Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 900 of 1475 entries
View as:

Healthcare Costs Among Patients With CML Receiving Dasatinib or Nilotinib in a Commercial and Medicare Population

Phase: N/A Priority: Normal
NCT ID: NCT02363868 Org: User:
Start: 02/28/14 End: 11/30/14 Due: 11/30/15

An Observational Study of the Functional Capacity of Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT02350114 Org: User:
Start: 11/30/14 End: 07/31/15 Due: 07/31/16

Safety and Efficacy Trial of Ipilimumab Versus Pemetrexed in Non-Squamous Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01471197 Org: User:
Start: 07/31/12 End: 02/28/13 Due: 02/28/14

A Study Evaluating the Associations Between Clinical Characteristics and Use of Oral Anticoagulants in Italian Elderly Participants With Non-Valvular Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT05232643 Org: User:
Start: 07/09/20 End: 11/30/25 Due: 11/30/26

Efficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT02388906 Org: User:
Start: 03/16/15 End: 10/16/24 Due: 10/16/25

A Study to Assess the Absorption of a Single Dose of BMS-986205 in Healthy Volunteers When Administered as a Crushed Tablet Orally or Crushed Tablet Suspension Via Nasogastric Tube, as Compared to a Tablet

Phase: N/A Priority: Normal
NCT ID: NCT03362411 Org: User:
Start: 11/09/17 End: 02/01/18 Due: 02/01/19

Belatacept Pharmacokinetic Trial in Renal Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00578448 Org: User:
Start: 03/31/08 End: 09/30/12 Due: 09/30/13

A Study to Assess the Levels in Blood Plasma of BMS-986278 in Healthy Participants Following Administration of Tablets, With or Without Food, and in the Presence of an Antacid (Esomeprazole)

Phase: N/A Priority: Normal
NCT ID: NCT04468815 Org: User:
Start: 07/10/20 End: 10/07/20 Due: 10/07/21

Safety and Effectiveness of Abatacept in Psoriatic Arthritis Participants

Phase: N/A Priority: Normal
NCT ID: NCT03419143 Org: User:
Start: 03/02/18 End: 03/31/22 Due: 03/31/23

A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00508157 Org: User:
Start: 11/30/07 End: 03/31/09 Due: 03/31/10

Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone

Phase: N/A Priority: Normal
NCT ID: NCT00095030 Org: User:
Start: 02/29/04 End: 03/31/06 Due: 03/31/07

A Multiple Dose Study to Assess the Safety and Tolerability of BMS-986166 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03038711 Org: User:
Start: 02/01/17 End: 08/10/17 Due: 08/10/18

Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT01448044 Org: User:
Start: 12/31/11 End: 01/31/14 Due: 01/31/15

Study of Reyataz in HIV-infected Patients With Lipodystrophy Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00135356 Org: User:
Start: 07/31/05 End: 06/30/08 Due: 06/30/09

Pharmacokinetics of Efavirenz in HIV-1 Infected Subjects With Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT00162097 Org: User:
Start: 11/30/04 End: 03/31/08 Due: 03/31/09

Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141)

Phase: N/A Priority: Normal
NCT ID: NCT02105636 Org: User:
Start: 05/29/14 End: 09/10/21 Due: 09/10/22

Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA)

Phase: N/A Priority: Normal
NCT ID: NCT03881059 Org: User:
Start: 04/01/19 End: 01/27/21 Due: 01/27/22

A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00095823 Org: User:
Start: 06/30/04 End: 08/31/06 Due: 08/31/07

Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-986120 in Healthy Subjects and the Effects of Co-Administration of Midazolam and BMS-986120

Phase: N/A Priority: Normal
NCT ID: NCT02208882 Org: User:
Start: 08/31/14 End: 02/28/15 Due: 02/28/16

Persistence, Adherence and Clinical Effectiveness of Entecavir in Chronic Hepatitis B Patients

Phase: N/A Priority: Normal
NCT ID: NCT01356901 Org: User:
Start: 01/31/11 End: 01/31/15 Due: 01/31/16

A Study to Assess the Effect of CC-95251 in Participants With Acute Myeloid Leukemia and Myelodysplastic Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT05168202 Org: User:
Start: 01/19/22 End: 07/30/24 Due: 07/30/25

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

Phase: N/A Priority: Normal
NCT ID: NCT06951711 Org: User:
Start: 06/17/25 End: 11/02/26 Due: 11/02/27

A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT03486912 Org: User:
Start: 06/12/18 End: 09/14/21 Due: 09/14/22

Study to Assess Clinical Outcomes in Chronic Hepatitis C Patients Previously Treated With Daclatasvir-Based Regimens

Phase: N/A Priority: Normal
NCT ID: NCT03366610 Org: User:
Start: 04/28/17 End: 04/30/19 Due: 04/30/20

Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)

Phase: N/A Priority: Normal
NCT ID: NCT01668784 Org: User:
Start: 10/09/12 End: 07/19/21 Due: 07/19/22